Literature DB >> 15632011

Enhanced susceptibility to endotoxic shock and impaired STAT3 signaling in CD31-deficient mice.

Michael Carrithers1, Suman Tandon, Sandra Canosa, Michael Michaud, Donnasue Graesser, Joseph A Madri.   

Abstract

Platelet endothelial cell adhesion molecule-1 (PECAM-1, CD31), an adhesion molecule expressed on hematopoietic and endothelial cells, mediates apoptosis, cell proliferation, and migration and maintains endothelial integrity in addition to its roles as a modulator of lymphocyte and platelet signaling and facilitator of neutrophil transmigration. Recent data suggest that CD31 functions as a scaffolding protein to regulate phosphorylation of the signal transducers and activators of transcription (STAT) family of signaling molecules, particularly STAT3 and STAT5. STAT3 regulates the acute phase response to innate immune stimuli such as lipopolysaccharide (LPS) and promotes recovery from LPS-induced septic shock. Here we demonstrate that CD31-deficient mice have reduced survival during endotoxic LPS-induced shock. As compared to wild-type controls, CD31-deficient mice showed enhanced vascular permeability; increased apoptotic cell death in liver, kidney, and spleen; and elevated levels of serum tumor necrosis factor alpha (TNF-alpha), interferon gamma (IFNgamma), MCP-1, MCP-5, sTNRF, and IL-6. In response to LPS in vivo and in vitro, splenocytes and endothelial cells from knockout mice had reduced levels of phosphorylated STAT3. These results suggest that CD31 is necessary for maintenance of endothelial integrity and prevention of apoptosis during septic shock and for STAT3-mediated acute phase responses that promote survival during septic shock.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15632011      PMCID: PMC1602311          DOI: 10.1016/S0002-9440(10)62243-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells.

Authors:  Chandrashekhar Pasare; Ruslan Medzhitov
Journal:  Science       Date:  2003-01-16       Impact factor: 47.728

2.  Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver.

Authors:  T Alonzi; D Maritano; B Gorgoni; G Rizzuto; C Libert; V Poli
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

3.  Platelet-endothelial cell adhesion molecule-1 (CD31), a scaffolding molecule for selected catenin family members whose binding is mediated by different tyrosine and serine/threonine phosphorylation.

Authors:  N Ilan; L Cheung; E Pinter; J A Madri
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

4.  PECAM-1 promotes beta-catenin accumulation and stimulates endothelial cell proliferation.

Authors:  Purba Biswas; Sandra Canosa; Jonathan Schoenfeld; David Schoenfeld; Adeline Tucker; Joseph A Madri
Journal:  Biochem Biophys Res Commun       Date:  2003-03-28       Impact factor: 3.575

5.  Platelet-endothelial cell adhesion molecule-1 modulates endothelial migration through its immunoreceptor tyrosine-based inhibitory motif.

Authors:  Dita Gratzinger; Mark Barreuther; Joseph A Madri
Journal:  Biochem Biophys Res Commun       Date:  2003-01-31       Impact factor: 3.575

6.  Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation.

Authors:  E Faure; L Thomas; H Xu; A Medvedev; O Equils; M Arditi
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

Review 7.  The immunopathogenesis of sepsis.

Authors:  Jonathan Cohen
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

8.  Transendothelial migration leads to protection from starvation-induced apoptosis in CD34+CD14+ circulating precursors: evidence for PECAM-1 involvement through Akt/PKB activation.

Authors:  Elisabetta Ferrero; Daniela Belloni; Paola Contini; Chiara Foglieni; Maria Elena Ferrero; Monica Fabbri; Alessandro Poggi; Maria Raffaella Zocchi
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

9.  Modulation of the nuclear factor kappa B pathway by Shp-2 tyrosine phosphatase in mediating the induction of interleukin (IL)-6 by IL-1 or tumor necrosis factor.

Authors:  M You; L M Flick; D Yu; G S Feng
Journal:  J Exp Med       Date:  2001-01-01       Impact factor: 14.307

10.  PECAM-1 (CD31) functions as a reservoir for and a modulator of tyrosine-phosphorylated beta-catenin.

Authors:  N Ilan; S Mahooti; D L Rimm; J A Madri
Journal:  J Cell Sci       Date:  1999-09       Impact factor: 5.285

View more
  59 in total

1.  Preeclampsia does not alter vascular growth and expression of CD31 and vascular endothelial cadherin in human placentas.

Authors:  Yan Li; Ying-Jie Zhao; Qing-Yun Zou; Kevin Zhang; Yan-Ming Wu; Chi Zhou; Kai Wang; Jing Zheng
Journal:  J Histochem Cytochem       Date:  2014-10-31       Impact factor: 2.479

2.  CD31 signals confer immune privilege to the vascular endothelium.

Authors:  Kenneth Cheung; Liang Ma; Guosu Wang; David Coe; Riccardo Ferro; Marco Falasca; Christopher D Buckley; Claudio Mauro; Federica M Marelli-Berg
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-21       Impact factor: 11.205

3.  The anti-inflammatory actions of platelet endothelial cell adhesion molecule-1 do not involve regulation of endothelial cell NF-kappa B.

Authors:  Jamie R Privratsky; Benjamin E Tourdot; Debra K Newman; Peter J Newman
Journal:  J Immunol       Date:  2010-02-19       Impact factor: 5.422

4.  Platelet-endothelial cell adhesion molecule-1 regulates endothelial NO synthase activity and localization through signal transducers and activators of transcription 3-dependent NOSTRIN expression.

Authors:  Margaret E McCormick; Reema Goel; David Fulton; Stefanie Oess; Debra Newman; Ellie Tzima
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-12-23       Impact factor: 8.311

5.  CD44: target for antiangiogenesis therapy.

Authors:  Horace M DeLisser
Journal:  Blood       Date:  2009-12-10       Impact factor: 22.113

6.  An alternatively spliced isoform of PECAM-1 is expressed at high levels in human and murine tissues, and suggests a novel role for the C-terminus of PECAM-1 in cytoprotective signaling.

Authors:  Carmen Bergom; Cathy Paddock; Cunji Gao; Trudy Holyst; Debra K Newman; Peter J Newman
Journal:  J Cell Sci       Date:  2008-04-15       Impact factor: 5.285

7.  PECAM-1 affects GSK-3beta-mediated beta-catenin phosphorylation and degradation.

Authors:  Purba Biswas; Sandra Canosa; David Schoenfeld; Jonathan Schoenfeld; Puyau Li; Lydia C Cheas; Jin Zhang; Alfredo Cordova; Bauer Sumpio; Joseph A Madri
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

Review 8.  PECAM-1: regulator of endothelial junctional integrity.

Authors:  Jamie R Privratsky; Peter J Newman
Journal:  Cell Tissue Res       Date:  2014-01-17       Impact factor: 5.249

9.  Site-specific effects of PECAM-1 on atherosclerosis in LDL receptor-deficient mice.

Authors:  Reema Goel; Benjamin R Schrank; Shikha Arora; Brian Boylan; Barbara Fleming; Hiroto Miura; Peter J Newman; Robert C Molthen; Debra K Newman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-31       Impact factor: 8.311

10.  Regulation of endothelial cell barrier function by antibody-driven affinity modulation of platelet endothelial cell adhesion molecule-1 (PECAM-1).

Authors:  Heng Mei; Jay M Campbell; Cathy M Paddock; Panida Lertkiatmongkol; Michael W Mosesson; Ralph Albrecht; Peter J Newman
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.